Detalles de la búsqueda
1.
Quality of life in women with early-stage and metastatic hormone receptor-positive, HER2-negative breast cancer receiving endocrine therapy.
Oncologist;
2024 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38906704
2.
The impact of expanded access programs for systemic anticancer therapy in an Irish cancer centre.
Ir J Med Sci;
2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38806877
3.
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J.
Clin Cancer Res;
30(7): 1273-1280, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38433347
4.
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial.
Nat Cancer;
5(6): 866-879, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38355777
5.
Enablers and barriers to accessing self-management support services for those living with and beyond cancer: A qualitative study using the theoretical domains framework.
Psychooncology;
33(1): e6254, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38047708
6.
The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial.
Nat Med;
29(11): 2814-2824, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37857711
7.
Room to Improve: An Audit of In-Hospital End-of-Life Care for Oncology Patients in a Tertiary Cancer Centre in Ireland During the COVID-19 Pandemic.
Omega (Westport);
: 302228231196620, 2023 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37670454
8.
Impact of Muscle Measures on Outcome in Patients Receiving Endocrine Therapy for Metastatic Breast Cancer: Analysis of ECOG-ACRIN E2112.
J Natl Compr Canc Netw;
21(9): 915-923.e1, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37673107
9.
Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial).
J Nucl Med;
64(11): 1690-1696, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37652539
10.
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes.
Breast Cancer Res Treat;
202(1): 191-201, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37589839
11.
A pilot project investigating the use of ONCOpatient®-An electronic patient-reported outcomes app for oncology patients.
Digit Health;
9: 20552076231185428, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37426594
12.
Improving quality of life and symptom experience in patients with metastatic breast cancer: A systematic review of supportive care interventions.
Psychooncology;
32(8): 1192-1207, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37434307
13.
A Phase I Study of a Combination of Liposomal Irinotecan and Veliparib in Solid Tumors.
Oncologist;
28(5): 460-e298, 2023 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37010988
14.
Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases.
Clin Cancer Res;
29(8): 1450-1459, 2023 04 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36705597
15.
Cost and public reimbursement of cancer medicines in the UK and the Republic of Ireland.
Ir J Med Sci;
192(2): 541-548, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35449390
16.
Back to the Beginning: The Role of Ovarian Suppression in Management of Hormone Sensitive Breast Cancer in Premenopausal Women.
J Clin Oncol;
41(7): 1339-1341, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36521079
17.
Correction: The Women's Health Initiative cancer survivorship clinic incorporating electronic patient-reported outcomes: a study protocol for the Linking You to Support and Advice (LYSA) randomized controlled trial.
Pilot Feasibility Stud;
8(1): 255, 2022 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36510292
18.
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013.
NPJ Breast Cancer;
8(1): 134, 2022 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36585404
19.
Automated lesion detection of breast cancer in [18F] FDG PET/CT using a novel AI-Based workflow.
Front Oncol;
12: 1007874, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36457510
20.
The Women's Health Initiative cancer survivorship clinic incorporating electronic patient-reported outcomes: a study protocol for the Linking You to Support and Advice (LYSA) randomized controlled trial.
Pilot Feasibility Stud;
8(1): 238, 2022 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36357934